Your browser doesn't support javascript.
loading
Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancer.
Chen, Xi; Xu, Jin; Guo, Qingcheng; Wang, Lingfei; Yang, Yun; Guo, Huaizu; Gu, Nana; Zhang, Dapeng; Qian, Weizhu; Hou, Sheng; Li, Jing; Dai, Jianxin; Guo, Yajun; Wang, Hao.
Afiliação
  • Chen X; International Joint Cancer Institute, Second Military Medical University, Shanghai, China; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China.
  • Xu J; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; Shanghai Zhangjiang Biotechnology Co. Ltd, Shanghai, China.
  • Guo Q; International Joint Cancer Institute, Second Military Medical University, Shanghai, China; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China.
  • Wang L; International Joint Cancer Institute, Second Military Medical University, Shanghai, China; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China.
  • Yang Y; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
  • Guo H; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; Shanghai Zhangjiang Biotechnology Co. Ltd, Shanghai, China.
  • Gu N; Shanghai Zhangjiang Biotechnology Co. Ltd, Shanghai, China.
  • Zhang D; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; Shanghai Zhangjiang Biotechnology Co. Ltd, Shanghai, China; School of Pharmacy, Liaocheng University, Liaocheng, China.
  • Qian W; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; Shanghai Zhangjiang Biotechnology Co. Ltd, Shanghai, China; Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos 138673, Singapore.
  • Hou S; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; Shanghai Zhangjiang Biotechnology Co. Ltd, Shanghai, China; School of Pharmacy, Liaocheng University, Liaocheng, China.
  • Li J; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; Shanghai Zhangjiang Biotechnology Co. Ltd, Shanghai, China.
  • Dai J; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; Shanghai Zhangjiang Biotechnology Co. Ltd, Shanghai, China; School of Pharmacy, Liaocheng University, Liaocheng, China.
  • Guo Y; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; School of Pharmacy, Liaocheng University, Liaocheng, China; School of Bioscience and Bioengineering, South China University of Technology, Guangzhou, China; Institute of Molecular and Cell Biology, 61 Biopolis Drive, Pr
  • Wang H; International Joint Cancer Institute, Second Military Medical University, Shanghai, China; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; School of Pharmacy, Liaocheng University, Liaocheng, China. Electronic address: hwang_smmu@163.com.
Biochem Biophys Res Commun ; 480(2): 160-165, 2016 11 11.
Article em En | MEDLINE | ID: mdl-27720718
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Neoplasias Colorretais / Anticorpos Monoclonais / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Neoplasias Colorretais / Anticorpos Monoclonais / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article